Tag: Bharat Biotech

Covid: It is expected that all 18-plus beneficiaries will be vaccinated by Dec 2021, says govt

The pace of COVID-19 vaccination across India is amongst the fastest in the world and in view of the evolving nature of the pandemic, it...

Sudden surge in Covid cases in Russia delays Sputnik’s commercial rollout in India

A sudden surge in Covid-19 cases in Russia has delayed large-scale commercial rollout of Sputnik V vaccine in India. There has been a delay of...

Brazil Opens Criminal Probe Into President Over Indian Vaccine Deal

SÃO PAULO—Brazil’s Supreme Court authorized prosecutors to investigate President Jair Bolsonaro over accusations he ignored alleged irregularities in his government’s procurement process to buy India’s...

jair bolsonaro: Bolsonaro in a bind over suspected graft in India vaccine deal

There was something fishy about the invoice: why was a company in Singapore billing Brazil $45 million for an Indian Covid-19 vaccine that hadn’t been...

News Live Updates: Bharat Biotech has submitted Covaxin’s Phase III trial data to DCGI, says Government sources

Bharat Biotech’s Covaxin is one of the three vaccines which are currently being used in India. The phase III data of its vaccine have been...

Bharat Biotech shares elaborate data of all research studies of Covaxin

India’s first indigenous COVID-19 vaccine manufacturer- Bharat Biotech on Saturday shared comprehensive data of all research studies of Covaxin. As per the company release, the...

View: How financial incentives for innovation can play a significant role in vaccine development

The world has witnessed an unprecedented race by the private sector to develop and produce Covid-19 vaccines. Since the outbreak of the pandemic, at least...

Covaxin puzzle: 6 crore shots ready, 2 crore given. Where are the rest?

(This story originally appeared in on May 28, 2021) The mismatch between reported production numbers of Covid vaccines in India and the level of daily...

Government steps in to expedite WHO approval for Covaxin

(This story originally appeared in on May 23, 2021) NEW DELHI: India’s Covaxin may have proven and adequate efficacy but its lack of endorsement from...

Covid crisis in India a warning of possible events in other low- and middle-income countries: IMF

Observing that the ongoing “catastrophic” second wave of COVID-19 in India is a sign that the worst may be yet to come, the IMF has...

Can Adityanath appoint a best-in-class administrator to lead a mammoth vaccination effort in UP?

Last Friday, on May 14, this paper published a graphic breaking down GoI’s ambitious vaccine production plan. Three approved producers of Covid-19 vaccines — Serum...

No financial aid given to SII & Bharat Biotech: Govt in SC | India News

NEW DELHI: Clearing a cloud of claims over monetary aid given to Covid-19 vaccine manufacturers, the Centre informed the Supreme Court that it has provided...

Centre indulging in politics over supply of vaccines: Jharkhand health minister | India News

RANCHI: Battling severe vaccine shortage, the Jharkhand government hit out at the Centre and alleged that it was “indulging in politics” by not providing the...

Finance Ministry: Budget heading for vaccination expenditure does not inhibit Centre from using funds: Finance ministry

The finance ministry on Monday said provisioning Rs 35,000 crore-expenditure for vaccines in the Union Budget for FY22 under the title ‘Transfers to States’ does...

GoI ‘left the ball’ by not becoming an early stakeholder in Covid vaccine production

In the otherwise sporting game of cricket, I find the practice of giving the benefit of the doubt quite irksome. This isn’t because I don’t...

Cap Covid-19 medicines, vax prices, issue compulsory license to scale up output: RSS-affiliate SJM to govt

Rashtriya Swayamsevak Sangh-affiliate Swadeshi Jagran Manch (SJM) has urged the Centre to provide regulatory clearance for the local production of the Russian Sputnik V vaccine,...

Apply the law to accelerate Covaxin output: Legal experts say sufficient legal provisions to ask several private companies to make the vaccine

Of the many ways India can ramp up vaccine production, widely sharing output responsibilities of Covaxin can be one of the most effective. Legal experts...

View: Express vaccination is our saviour

India is reeling under the second wave of the pandemic. On April 25, 2021, we reported over 3.5 lakh cases of fresh infections from the...

Civil society petition in SC for compulsory licence for vaccine, key Covid drugs

Civil society organisation Jan Swasthya Abhiyan (Mumbai) has filed a petition in the Supreme Court seeking direction to the Centre to issue compulsory licenses for...

india covid vaccination: Mass vaccination, India’s COVID-19 escape route, poses a giant challenge

India is the world’s leading producer of vaccines, but over the past week it has also been the global leader in COVID-19 deaths, and it...

South awaits vaccine supply timelines to fix launch dates

Five major southern states will be able to kick off the vaccination campaign for people in the 18-44 year age group only after a week...

Inoculation 3.0: South waiting for supply timeline from vaccine makers before committing to launch date

Five major southern states will be able to kick-off the vaccination campaign for people in the 18-44 year age group only after a week or...

US should grant India special waiver from DPA for vaccine raw materials

The United States ought to consider granting India a special exemption or waiver from the imposition of its Defence Production Act (DPA) on raw materials...

Vaccination drive for all above 18 years may get delayed as states yet to get a clarity on delivery

Registration for vaccinations for all above the age of 18 may have started on Wednesday but there seems to be a slip between the cup...

Covid-19: States unsure of vaccination Phase 3 | India News

NEW DELHI: It’s just two more days to India’s third phase of vaccination to begin – which will see those between 18 and 45 years...